4.7 Review

Cervicovaginal microbiota, women's health, and reproductive outcomes

期刊

FERTILITY AND STERILITY
卷 110, 期 3, 页码 327-336

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2018.06.036

关键词

Sexually transmitted diseases; pelvic inflammatory disease; bacterial vaginosis; in vitro fertilization; contraception

资金

  1. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI084044, R01NR014784, R01NR014826, R01AI116799]
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044, R01AI116799] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014784, R01NR014826] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The human microbiome project has shown a remarkable diversity of microbial ecology within the human body. The vaginal microbiota is unique in that in many women it is most often dominated by Lactobacillus species. However, in some women it lacks Lactobacillus spp. and is comprised of a wide array of strict and facultative anaerobes, a state that broadly correlates with increased risk for infection, disease, and poor reproductive and obstetric outcomes. Interestingly, the level of protection against infection can also vary by species and strains of Lactobacillus, and some species although dominant are not always optimal. This factors into the risk of contracting sexually transmitted infections and possibly influences the occurrence of resultant adverse reproductive outcomes such as tubal factor infertility. The composition and function of the vaginal microbiota appear to play an important role in pregnancy and fertility treatment outcomes and future research in this field will shed further translational mechanistic understanding onto the interplay of the vaginal microbiota with women's health and reproduction. ((C) 2018 by American Society for Reproductive Medicine.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据